Who owns IONIS PHARMACEUTICALS INC?
- CUSIP Number: 462222af7
Tip: Access positions for across all investors
Analyze quarterly positions in Ionis Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ionis Pharmaceuticals stock
Who bought or sold IONIS PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ing Investment Management | 96M | $132M | 27% | Sep 2025 |
|
| Deerfield Management Company | 60M | $83M | 100% | Sep 2025 |
|
| Camden Asset Management | 48M | $67B | -36% | Sep 2025 |
|
| Lazard Asset Management | 37M | $518k | -11% | Sep 2025 |
|
| Wolverine Asset Management | 29M | $40M | -29% | Sep 2025 |
|
| Wellington Management Company | 28M | $39M | -3% | Sep 2025 |
|
| MacKay Shields | 28M | $39M | 0% | Sep 2025 |
|
| Calamos Advisors | 26M | $36M | 0% | Sep 2025 |
|
| BlackRock | 25M | $35M | -12% | Sep 2025 |
|
| DLD Asset Management | 25M | $35M | 100% | Sep 2025 |
|
| CSS | 25M | $34M | 100% | Sep 2025 |
|
| Linden Advisors | 20M | $28M | 673% | Sep 2025 |
|
| Morgan Stanley | 15M | $16M | 100% | Jun 2025 |
|
| State Street Corporation | 12M | $17M | 9% | Sep 2025 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 12M | $16M | 74% | Sep 2025 |
|
| Advent Capital Management | 9.3M | $13M | -80% | Sep 2025 |
|
| Ameriprise Financial | 9.0M | $12M | -25% | Sep 2025 |
|
| Royal Bank of Canada | 8.0M | $11M | 15% | Sep 2025 |
|
| FMR | 7.0M | $9.7M | -4% | Sep 2025 |
|
| Wells Fargo & Company | 6.9M | $9.5M | 1202% | Sep 2025 |
|
| M&G | 6.3M | $8.7M | 100% | Sep 2025 |
|
| Sonora Investment Management Group | 5.3M | $7.3M | 0% | Sep 2025 |
|
| Shenkman Capital Management | 5.1M | $7.1B | -25% | Sep 2025 |
|
| State of Wisconsin Investment Board | 3.0M | $4.1M | 50% | Sep 2025 |
|
| Bnp Paribas Investment Partners | 2.5M | $3.4M | 0% | Sep 2025 |
|
| RWC Asset Management | 2.4M | $3.3M | -19% | Sep 2025 |
|
| Jpmorgan Chase & Co | 2.2M | $3.0M | 72% | Sep 2025 |
|
| SSI Investment Management | 2.0M | $2.8M | 0% | Sep 2025 |
|
| Westwood Holdings | 2.0M | $2.8M | 0% | Sep 2025 |
|
| Man Group | 1.6M | $2.2M | -28% | Sep 2025 |
|
| Union Bancaire Privee, UBP SA | 1.4M | $1.7M | 0% | Sep 2025 |
|
| Kohlberg Kravis Roberts & Co | 1.4M | $1.9M | 112% | Sep 2025 |
|
| Bank Of Montreal | 1.3M | $1.3M | 100% | Jun 2025 |
|
| AXA Investment Managers | 935k | $612k | 100% | Sep 2025 |
|
| Goldman Sachs Group | 810k | $1.1M | 100% | Sep 2025 |
|
| Deutsche Bank Aktiengesellschaft | 720k | $995k | -18% | Sep 2025 |
|
| Palisade Capital Management | 500k | $691k | -50% | Sep 2025 |
|
| Zurcher Kantonalbank | 500k | $691k | 0% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 391k | $540k | 8% | Sep 2025 |
|
| Sei Investments | 262k | $362k | 0% | Sep 2025 |
|
| Barclays | 203k | $280k | -81% | Sep 2025 |
|
| Calamos Wealth Management | 144k | $199k | 0% | Sep 2025 |
|
| Branch Banking & Trust Company | 73k | $101k | 0% | Sep 2025 |
|
| Lombard Odier Asset Management | 73k | $15M | 100% | Sep 2025 |
|
| Nomura Holdings | 52k | $3.4M | 53% | Sep 2025 |
|
| UBS Group | 17k | $24k | 100% | Sep 2025 |
|
| Erste Asset Management GmbH | 0 | $0 | -100% | Sep 2025 |
|
Who sold out of Ionis Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Nuveen | Jun 2025 | 12M | $12M |
| New York State Common Retirement Fund | Jun 2025 | 8.1M | $8.5M |
| Tenor Capital Management | Jun 2025 | 8.0M | $8.4M |
| Amundi | Jun 2025 | 3.3M | $3.6M |
| Axa | Jun 2025 | 2.0M | $2.1M |
| Leucadia National Corporation | Jun 2025 | 1.2M | $1.3M |
| Insigneo Advisory Services | Jun 2025 | 21k | $22k |